feed,title,long_url,short_url
Benzinga,Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers,https://www.benzinga.com/pressreleases/20/07/n16611249/blueprint-medicines-announces-global-collaboration-with-roche-to-develop-and-commercialize-pralset,https://j.mp/2OmvNL5
